💼 Business
12h ago
Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial
Source ↗
👁 0
💬 0
Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone for gene editing.
Comments (0)